Intravenous ketamine infusion as an adjuvant to morphine in a 2-year-old with severe cancer pain from metastatic neuroblastoma.
Tsui
Ban C H
BC
Department of Anesthesiology and Pain Medicine, University of Alberta, Edmonton, Alberta, Canada. btsui@ualberta.ca
Davies
Dawn
D
Desai
Sunil
S
Malherbe
Stephan
S
D000284:Administration, Oral; D018712:Analgesics, Non-Narcotic / Q000008:administration & dosage / Q000627:therapeutic use*; D000701:Analgesics, Opioid / Q000008:administration & dosage / Q000627:therapeutic use*; D002675:Child, Preschool; D003061:Codeine / Q000008:administration & dosage / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D004417:Dyspnea / Q000139:chemically induced; D017809:Fatal Outcome; D005260:Female; D006212:Hallucinations / Q000139:chemically induced; D006801:Humans; D007262:Infusions, Intravenous; D007649:Ketamine / Q000008:administration & dosage / Q000627:therapeutic use*; D008691:Methadone / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D009020:Morphine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D009447:Neuroblastoma / Q000503:physiopathology*; D010148:Intractable Pain / Q000188:drug therapy* / Q000209:etiology; D010166:Palliative Care; D011788:Quality of Life
D018712:Analgesics, Non-Narcotic; D000701:Analgesics, Opioid; D007649:Ketamine; D009020:Morphine; D008691:Methadone; D003061:Codeine